相关实验视频
Updated: Jun 1, 2025

03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
593
您需要知道的:恶性多叶膜溢出的管理
1Department of Respiratory Medicine, Western General Hospital, Edinburgh, UK.
British journal of hospital medicine (London, England : 2005)
|January 20, 2025
概括
恶性肺流 (MPE) 管理侧重于缓解晚期癌症的症状. 目前的策略包括成像,多液吸收,用于分子测试的活检,以及诸如多或导管插入等干预措施.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 内部医学 内部医学
背景情况:
- 恶性流 (MPE) 是晚期癌症的常见并发症,表明预后不佳.
- 对于MPE患者的中位生存时间在3至12个月之间.
- 尽管癌症治疗取得了进展,但MPE症状缓解仍然是主要的治疗目标.
研究的目的:
- 审查目前对恶性多流的评估和管理的指导方针和证据.
- 突出MPE不断变化的诊断和治疗场景.
主要方法:
- 审查目前关于MPE评估和管理的指导方针和证据.
- 讨论用于评估的成像技术 (CXR,CT,超声波).
- 评估诊断程序 (肺吸收,活检) 和管理选项 (治疗吸收,肺,内置肺导管).
主要成果:
- 评估依赖于成像 (CXR,CT) 和超声指导程序.
- 胸腔吸收是诊断的关键,但产量各不相同;在向治疗和免疫治疗时代,活检越来越需要用于分子测试.
- 管理选项包括治疗性吸收,化学膜切除和内置性膜导管,每个都有特定的好处.
结论:
- 恶性流管理需要以患者为中心的方法,整合诊断和治疗.
- 专家管理,最好是门诊,可以改善患者的治疗结果和生活质量.
- 设备和综合治疗方法的进步提高了MPE患者的护理.
相关概念视频
Pleural Effusion II: Symptoms and Management
151
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
151
Pleural Effusion I: Introduction
503
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
503
Pneumothorax-II
119
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
119
Pneumonia V: Nursing management and Prevention
1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Pleural Disorders: Types and Brief Description
183
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
183
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123

